Insmed (INSM) Non-Current Assets (2010 - 2026)

Insmed's (INSM) quarterly Non-Current Assets came in at $462.7 million in Q1 2026, up 15.66% year-on-year from $400.0 million in Q1 2025, and down 1.63% quarter-over-quarter from $470.4 million in Q4 2025.

Insmed (INSM) Non-Current Assets (2010 - 2026) Analysis & Trends

Insmed's Non-Current Assets history runs 17 years deep, the most recent figure standing at $462.7 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 15.66% year-over-year to $462.7 million in Q1 2026; TTM through Mar 2026 was $1.8 billion, a 10.11% increase from a year earlier, with the FY2025 full-year figure at $470.4 million, up 16.55% from the prior year.
  • Non-Current Assets eased to $462.7 million in Q1 2026 per INSM's latest filing, from $470.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $470.4 million in Q4 2025 and bottomed at $362.7 million in Q3 2022.
  • The 5-year median for Non-Current Assets is $398.3 million (2023), against an average of $403.2 million.
  • Biggest YoY gain for Non-Current Assets was 107.52% in 2022; the steepest drop was 5.76% in 2022.
  • Year by year, Non-Current Assets stood at $383.1 million in 2022, then climbed by 4.63% to $400.8 million in 2023, then rose by 0.7% to $403.6 million in 2024, then increased by 16.55% to $470.4 million in 2025, then dropped by 1.63% to $462.7 million in 2026.
  • Per Business Quant, the three latest INSM Non-Current Assets figures stand at $462.7 million (Q1 2026), $470.4 million (Q4 2025), and $428.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn 462.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 462.69 Mn
Dec 31, 2025 470.35 Mn
Sep 30, 2025 428.93 Mn
Jun 30, 2025 398.28 Mn
Mar 31, 2025 400.04 Mn
Dec 31, 2024 403.57 Mn
Sep 30, 2024 403.13 Mn
Jun 30, 2024 391.93 Mn
Mar 31, 2024 400.37 Mn
Dec 31, 2023 400.77 Mn
Sep 30, 2023 398.30 Mn
Jun 30, 2023 386.72 Mn
Mar 31, 2023 388.65 Mn
Dec 31, 2022 383.05 Mn
Sep 30, 2022 362.65 Mn
Jun 30, 2022 378.63 Mn
Mar 31, 2022 397.18 Mn
Dec 31, 2021 406.47 Mn
Sep 30, 2021 352.79 Mn
Jun 30, 2021 191.59 Mn